ERBB2 and breast carcinoma: 27 Ross Ross JS JS Slodkowska Slodkowska EA EA Symmans Symmans WF WF Pusztai Pusztai L L Ravdin Ravdin PM PM Hortobagyi Hortobagyi GN GN The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine Oncologist Oncologist 2009 2009 14 14 4 4 320 320 368 368 19346299 19346299 27.